DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Barr PM, Brown JR, Hillmen P, O'Brien S, Barrientos JC, Reddy NM. et al.
Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL.
Blood 2017;
129: 2612-5
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.